Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 81 of 95, showing 5 Applications out of 471 total, starting on record 401, ending on 405

# Protocol No Study Title Investigator(s) & Site(s)

401.

ECCT/16/10/01   INVICTUS
    INVESTIGATION OF RHEUMATIC AF TREATMENT USING VITAMIN K ANTAGONISTS, RIVAROXABAN OR ASPRIN STUDIES   
Principal Investigator(s)
1. Elijah Nyainda Ogola
2. felix ayub barasa
Site(s) in Kenya
1. Kenyatta National hospital (Nairobi City county)
2. Moi teaching and Referral Hospital (Uasin Gishu county)
3. The Karen Hospital (Nairobi City county)
 
View

402.

ECCT/21/10/05   Lactolize Study
    Lactoferrin and Lysozyme supplementation for long-term diarrhea sequelae   
Principal Investigator(s)
1. Benson Ochieng Singa
Site(s) in Kenya
1. Awendo Sub-County Hospital (Migori county)
2. Homa Bay County Referral Hospital (Homa Bay county)
3. Isebania Sub-County Hospital (Migori county)
4. Kendu Adventist Hospital (Homa Bay county)
5. Kisii Teaching and Referral Hospital (Kisii county)
6. Mbita Sub-County Hospital (Homa Bay county)
7. Rongo Sub-County Hospital (Migori county)
 
View

403.

ECCT/23/09/05   LCCC 2236 Study
    LCCC  2236: Phase I study of self-administered Artesunate pessaries (vaginal inserts) for treatment of cervical precancer in HIV positive and HIV-negative women in Kenya    
Principal Investigator(s)
1. Chemtai Mungo
2. Jackton Omoto
Site(s) in Kenya
FACES, Lumumba Sub-county Hospital
 
View

404.

ECCT/14/08/03   STAND Study (Shortening Treatment by Advancing Novel Drugs)
    Long Title:   A Phase 3 Open Label Partially Randomised Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug Sensitive Smear Positive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis       Short Title:   STAND Study (Shortening Treatment by Advancing Novel Drugs)   
Principal Investigator(s)
1. Dr Videlis Nduba
2. Dr Evans Amukoye
Site(s) in Kenya
1. KEMRI-CRDR(East Nairobi) (Nairobi City county)
2. KEMRI-CRDR(West Nairobi) (Nairobi City county)
 
View

405.

ECCT/23/05/07   LATA
    Long-Acting Treatment in Adolescents (LATA) A randomised open-label 2-arm 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in Sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1.
 
View